Have you seen the recent New York Times article, “The Opaque Industry Secretly Inflating Prices for Prescription Drugs”? This eye-opening piece by Rebecca Robbins and Reed Abelson reveals how pharmacy benefit managers (PBMs) are significantly driving up the costs of prescription drugs for millions of Americans, employers, and the government.
What Are PBMs?
Pharmacy Benefit Managers, or PBMs, are middlemen who manage prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers, and other payers. The three largest PBMs—CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth Group’s OptumRx—control a substantial portion of the prescription drug market. These PBMs are owned by massive healthcare conglomerates and are responsible for negotiating with drug manufacturers, paying pharmacies, and determining the cost and availability of drugs for consumers.
The Dark Side of PBMs
While PBMs are supposed to lower drug costs, the New York Times investigation found that they often do the opposite. Here are some of the key findings:
- Inflated Drug Prices: PBMs frequently push patients towards more expensive drugs, charge high markups on low-cost medications, and extract hidden fees from drug manufacturers, all of which inflate overall drug costs.
- Complex and Opaque System: The PBM industry operates in a highly opaque and complex manner, making it difficult for employers, patients, and even the government to understand or control drug pricing. This lack of transparency allows PBMs to prioritize their financial interests over the needs of patients.
- Impact on Independent Pharmacies: PBMs pay pharmacies on behalf of employers and insurers. However, they often reimburse independent pharmacies at rates too low to cover their costs, driving many out of business. This reduction in local pharmacies diminishes healthcare access, particularly in poorer communities.
- Delays and Denials of Medication: PBMs can delay or deny patient access to necessary medications, leading to serious health consequences. Many patients become aware of PBMs only when they face difficulty obtaining their prescriptions.
The Economic Impact
The business practices of PBMs affect virtually every American family, whether or not they directly take prescription drugs. Higher drug prices lead to increased insurance premiums and taxes. For example, in Oklahoma, Caremark overcharged a health plan by more than $120,000 annually for a single patient’s cancer medication.
The Legal and Political Landscape
There is growing scrutiny of PBMs from lawmakers, regulators, and attorneys general across the United States. Allegations include inflating drug prices and engaging in anti-competitive behavior. Attorney General Dave Yost has sued Express Scripts and OptumRx in Ohio, accusing them of extracting value from the healthcare system without creating corresponding benefits.
Gain Transparency by Speaking with Us
At The Medical Link, we can assess each specific plan that’s available and provide you with the specific cost differences to determine which may fit best for your organization. Many clients who take advantage of self-insurance options realize significant potential savings compared to their current plans. By leveraging The Medical Link’s services, you can navigate the complexities of the available benefits options with confidence, potentially leading to more affordable and accessible healthcare solutions.
If you would like more information, Click Here.
Source:
